Requires certain health insurers to provide coverage for counseling and behavioral therapies for any person receiving medication-assisted treatment.
Impact
If enacted, A1775 would amend existing New Jersey statutes concerning health benefits plans by compelling insurers to offer comprehensive coverage for mental health conditions and substance use disorders. This would bear significant implications for the state's approach to addiction treatment, particularly as it expands the scope of what is included under health benefit plans. The bill seeks to eliminate potential barriers for individuals seeking treatment for opioid addiction and ensures that the services rendered by healthcare professionals are accessible and equitable.
Summary
Assembly Bill A1775 focuses on enhancing health insurance coverage for individuals undergoing medication-assisted treatment (MAT) for substance use disorders. The bill mandates that specific health insurers in New Jersey provide coverage for not only the medications used in MAT but also for accompanying counseling and behavioral therapies. This law is positioned to align with federal mental health parity regulations, ensuring that mental health services, including treatment for substance use disorders, are covered on the same terms as other medical conditions.
Contention
While the bill proposes beneficial changes, it may face opposition from insurance companies concerned about the increased financial burden of mandated comprehensive coverage, which could lead to higher premiums for policyholders. Additionally, the requirement for insurers to provide coverage for counseling and therapies could stir debate regarding the extent of government intervention in healthcare policies. Nevertheless, advocates argue that the long-term benefits of comprehensive treatment access and successful recovery rates outweigh potential costs.
Carry Over
Requires certain health insurers to provide coverage for counseling and behavioral therapies for any person receiving medication-assisted treatment.